Should chronic HBV infected patients with normal ALT treated: Debate

28Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alanine aminotransferase (ALT) levels have traditionally been used for treatment decisions in chronic hepatitis B virus (CHBV) infected patients. But recent data have raised doubts on this wisdom, as a significant proportion of CHBV infected patients with normal ALT have high HBVDNA levels and significant liver injury at presentation especially in areas of intermediate to high endemicity. A normal ALT value only identifies patients less likely to respond to current treatments, rather than patients who are not in need of the treatment. Patients with CHBV infection with normal ALT should be considered for treatment based on the HBV DNA levels and histological injury. © Asian Pacific Association for the Study of the Liver 2008.

Author supplied keywords

Cite

CITATION STYLE

APA

Sarin, S. K., & Kumar, M. (2008). Should chronic HBV infected patients with normal ALT treated: Debate. Hepatology International. Springer New York. https://doi.org/10.1007/s12072-008-9065-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free